References
- JansonCStratelisGMiller-LarssonAHarrisonTWLarssonKScientific rationale for the possible inhaled corticosteroid intraclass difference in the risk of pneumonia in COPDInt J Chron Obstruct Pulmon Dis2017123055306429089754
- SohalSSHansbroPMShuklaSDEapenMSWaltersEHPotential mechanisms of microbial pathogens in idiopathic interstitial lung diseaseChest2017152489990028991543
- ShuklaSDMullerHKLathamRSohalSSWaltersEHPlatelet-activating factor receptor (PAFr) is upregulated in small airways and alveoli of smokers and COPD patientsRespirology201621350451026662379
- ShuklaSDSohalSSMahmoodMQReidDMullerHKWaltersEHAirway epithelial platelet-activating factor receptor expression is markedly upregulated in chronic obstructive pulmonary diseaseInt J Chron Obstruct Pulmon Dis2014985386125143722
- ShuklaSDFairbairnRLGellDAAn antagonist of the platelet-activating factor receptor inhibits adherence of both nontypeable Haemophilus influenzae and Streptococcus pneumoniae to cultured human bronchial epithelial cells exposed to cigarette smokeInt J Chron Obstruct Pulmon Dis2016111647165527524890
References
- ShuklaSDSohalSSMahmoodMQReidDMullerHKWaltersEHAirway epithelial platelet-activating factor receptor expression is markedly upregulated in chronic obstructive pulmonary diseaseInt J Chron Obstruct Pulmon Dis2014985386125143722
- HeijinkIHJonkerMRde VriesMBudesonide and fluticasone propionate differentially affect the airway epithelial barrierRespir Res201617226739349
- MarquesSADyLCSouthallMDThe platelet-activating factor receptor activates the extracellular signal-regulated kinase mitogen- activated protein kinase and induces proliferation of epidermal cells through an epidermal growth factor-receptor-dependent pathwayJ Pharmacol Exp Ther20023001026103511861812